Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2092]

SABCS 2020: High-risk, HR , HER2-, early-stage BC patients continue to benefit from abemaciclib

SABCS 2020: High-risk, HR , HER2-, early-stage BC patients continue to benefit from abemaciclib

SABCS 2020: Under-recognition of symptoms may be common in breast cancer patients receiving radiation

SABCS 2020: Under-recognition of symptoms may be common in breast cancer patients receiving radiation

SABCS 2020: CTC dynamics may predict treatment response/prognosis in metastatic breast cancer patients

SABCS 2020: CTC dynamics may predict treatment response/prognosis in metastatic breast cancer patients

SABCS 2020: Mastectomy and reconstructive surgery may lead to patients becoming persistent drug users

SABCS 2020: Mastectomy and reconstructive surgery may lead to patients becoming persistent drug users

Tiny nanospindles enhance use of ultrasound to fight cancer

Tiny nanospindles enhance use of ultrasound to fight cancer

A library of mice to look up the best liver cancer treatment

A library of mice to look up the best liver cancer treatment

ASH 2020: CRISPR-edited CAR T cells enhance fight against blood cancers

ASH 2020: CRISPR-edited CAR T cells enhance fight against blood cancers

Potential cancer therapy may boost immune response

Potential cancer therapy may boost immune response

Study finds obesity contributes to 40% mortality gap between Black and white women with early breast

Study finds obesity contributes to 40% mortality gap between Black and white women with early breast

ASH 2020: Follow up data on venetoclax in combination with rituximab or obinutuzumab for CLL shows continued survival benefit

ASH 2020: Follow up data on venetoclax in combination with rituximab or obinutuzumab for CLL shows continued...

More from ecancer